4HY8XJHGMx3GdWvwGEb5pcygqYkSwcXb6VIgXS2ULjx7sRs11oHIh9OsiMjN
Current position: Home >> Scientific Research >> Paper Publications

Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluation of WO2016059647(A2)

Hits:

Institution:药学院

Title of Paper:Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluation of WO2016059647(A2)

Journal:Expert Opinion on Therapeutic Patents

First Author:黄伯世

All the Authors:展鹏,刘新泳

Document Code:C692CFAD379E4CF0B195D7F473EFF772

Volume:27

Issue:1

Page Number:9

Translation or Not:No

Date of Publication:2017-01

Release Time:2019-10-25

Prev One:1-Hydroxypyrido[2,3-d]pyrimidin-2(1H)-ones as novel selective HIV integrase inhibitors obtained via privileged substructure-based compound libraries

Next One:Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV-1 RNase H inhibitors